Dr. Konstantin Vaizman, MD

Dr. Vaizman practices at Amboy Medical Practice in Staten Island, New York.

Dr. Vaizman's NPI, 1639268105, was assigned on October 12, 2006. Dr. Vaizman holds New York license 242086.

Dr. Vaizman's primary practice is Amboy Medical Practice, at 1058 Forest Ave, Staten Island, NY 10310 in Richmond County. The practice phone is (718) 818-3327.

Dr. Vaizman's primary practice is Amboy Medical Practice in Staten Island, New York. Dr. Vaizman is also affiliated with Richmond University Medical Center. The medical group on file is Amboy Medical Practice PC. Dmand AI also links Dr. Vaizman to 4 more group practices and clinics, 4 medical groups, 1 physician office and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Vaizman practices, 7 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Vaizman's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Vaizman is licensed in New York.

CMS data shows 618 Medicare services from Dr. Vaizman across 8 procedure codes in 2024, for 324 Medicare patients. Medicare paid $61,984 for them.

CMS counts 324 Medicare patients who saw Dr. Vaizman in 2024. The largest group is 65 to 74, with 161 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 74% are also on Medicaid. Their average risk score is 1.91, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Vaizman's median patient age at 60, with 59% women.

In 2024, Dr. Vaizman wrote 1,893 Medicare Part D claims for 396 patients. 86% of them were for generic drugs. CMS names the drug for 1,778 of them, across 22 drugs with 11 or more claims each, at $256,524 in total drug cost. In 2023, CMS named 1,332 claims across 19 drugs.

Dr. Vaizman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Vaizman as offering telehealth. CMS counts 118 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Vaizman, more than 80% of the clinicians it reports for that procedure.

CMS Open Payments shows 158 general payments to Dr. Vaizman from 16 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 96% of the total. Abbvie Inc. paid the most, $1,727.